Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Essentia Health - Deer River Clinic
mi
from
Deer River, MN
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Marshfield Clinic Cancer Center - Eau Claire
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Joseph Health System-Tawas City
mi
from
Tawas City, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Essentia Health Virginia Clinic
mi
from
Virginia, MN
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Leuven,
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Midvale, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Ulcerative Colitis (UC) Clinical Trial
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Boston Children's Hospital /ID# 147714
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Status: Enrolling, Phase I
Updated: 12/31/1969
Huntsman Cancer Institute SC
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Non-Erosive Reflux Disease Clinical Trial
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
Status: Enrolling
Updated: 12/31/1969
Queen Medical Center
mi
from
Nottingham,
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Hospital of Wisconsin-Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Previously Treated Non Small Cell Lung Cancer Clinical Trial
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer
Status: Enrolling, Phase II
Updated: 4/21/2015
Clinical Research Facility
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Status: Enrolling, Phase II
Updated: 4/10/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Status: Enrolling, Phase II
Updated: 4/10/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Clinical Trial
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Status: Enrolling, Phase II
Updated: 4/10/2015
Clinical Research Facility
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
London Health Sciences Centre - University Campus
mi
from
London,
Click here to add this to my saved trials
Oncology Clinical Trial
Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)
Status: Enrolling, Phase I, II
Updated: 12/15/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University Cancer & Blood Center, LLC; Research
mi
from
Athens, GA
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Hospital Cancer Inst; Memorial System Onc Clin Rsch
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Cancer Specialist, North Region
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Cancer Cnt Onco Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Midwestern Regional Medical Center
mi
from
Zion, IL
Click here to add this to my saved trials
Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trial
A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4
Status: Enrolling, Phase I
Updated: 12/31/1969
Site US00027
mi
from
Harvey, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal, Other Clinical Trial
Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media
Status: Enrolling, Phase II
Updated: 3/18/2014
Clinical Research Facility
mi
from
Gresham, OR
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Bronson Healthcare Group
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Dorothy Sander, RPh
mi
from
Bismarck, ND
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Consultorios Reumatologicos Pampa.
mi
from
C.a.b.a.,
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Baylor Scott and White Research Institute / Arthritis Care and Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of South Florida, College of Medicine, Internal Medicine-Rheumatology
mi
from
Tampa, FL
Click here to add this to my saved trials
Arthritis, Rheumatoid Clinical Trial
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Status: Enrolling, Phase IV
Updated: 12/31/1969
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Parkinson's Disease Clinical Trial
Single Ascending Dose Study of PRX002 in Healthy Subjects
Status: Enrolling, Phase I
Updated: 4/11/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Sickle Cell Clinical Research and Intervention Program
Status: Enrolling, Phase
Updated: 12/31/1969
Regional One Health, Diggs-Kraus Sickle Cell Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Advanced Solid Tumors Cancer Clinical Trial
A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors.
Status: Enrolling, Phase I
Updated: 12/31/1969
Henry Ford Health System /ID# 149857
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Germ Cell Tumor and Testicular Tumor DNA Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Germ Cell Tumor and Testicular Tumor DNA Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Uterine Fibroids Clinical Trial
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Gynecology Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
Status: Enrolling, Phase I
Updated: 4/4/2016
David A Eichenbaum, MD
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Hypophosphatasia HPP Clinical Trial
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hypophosphatasia HPP Clinical Trial
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Status: Enrolling
Updated: 4/2/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Ashland Memorial Medical Center
mi
from
Ashland, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Iowa Healthcare Cancer Services Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care-Southern Lakes VLCC
mi
from
Burlington, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Chelsea
mi
from
Chelsea, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Newland Medical Associates-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Northshore Oncology Associates-Covington
mi
from
Covington, LA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Saint Mary's - Detroit Lakes Clinic
mi
from
Detroit Lakes, MN
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
HSHS Sacred Heart Hospital
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
AMITA Health Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Genesee Hematology Oncology PC
mi
from
Flint, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Saint Mary's
mi
from
Green Bay, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Grosse Pointe Woods
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nevada Cancer Specialists-Fort Apache
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Nevada Cancer Specialists?Oakey
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth D N Greenwald Center
mi
from
Mukwonago, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
ProHealth Oconomowoc Memorial Hospital
mi
from
Oconomowoc, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Geisinger Cancer Services-Pottsville
mi
from
Pottsville, PA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Hematology Associates of Saginaw Valley PC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center at Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Mary's Oncology/Hematology Associates of West Branch
mi
from
West Branch, MI
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
mi
from
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
Status: Enrolling, Phase II
Updated: 2/14/2017
Austin Cancer Centers Austin Cancer Centers
mi
from
Austin, TX
Click here to add this to my saved trials
Endocrinology, Pharmacology / Toxicology, Orthopedics / Podiatry Clinical Trial
Longitudinal Studies of Brain Structure and Function in MPS Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Radiology Associates of Appleton/ThedaCare Regional Medical Center
mi
from
Appleton, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
University of Cincinnati/Barrett Cancer Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling, Phase III
Updated: 5/4/2017
AMITA Health Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials